Sygnature Discovery

Bio City, Pennyfoot Street
NG1 1GR Nottingham, Nottinghamshire
UK

Contact WebSite

Sygnature Discovery is a world-leading integrated drug discovery contract research organization based in the UK and Canada with headquarters in Nottingham (UK). Additional sites are located in Alderley Park, Macclesfield, and Glasgow (UK), as well as Montreal and Quebec City (Canada). Its team of over 1,000 employees, which includes 900 scientists, partners with global biotech, pharma and NFP organizations. Since 2011, Sygnature Discovery has delivered 56 novel pre-clinical and 35 clinical compounds, with its scientists named on over 235 patents. Therapeutic areas of expertise include oncology, inflammation and immunology, neuroscience, metabolic diseases, infectious diseases, fibrotic diseases, and more.

Article

Sygnature Discovery Unveils £1 Million Chemistry Facility Upgrade
25.07.2025 • NewsPharma

Sygnature Discovery Unveils £1 Million Chemistry Facility Upgrade

Sygnature Discovery, an integrated drug discovery CRO, has completed a major enhancement to its high-throughput chemistry (HTC) capabilities and laboratory infrastructure following a £1 million investment.